|St Andrews University, PhD|
Dr Brett Pollard has been active in the healthcare industry for over 10 years initially as an equity analyst. Before joining Abingdon Health Ltd in 2008 he was Head of Life Science Research at Numis where he led the team to Number 2 in the 2007 Extel ratings. Prior to his role at Numis, Brett spent time at Seymour-Pierce in London and at Deutsche Bank based in Frankfurt, Germany.
Brett has extensive corporate development experience and is a Director of Abingdon Health Limited, Bioscience Ventures Limited and Alta Bioscience Limited